Author Correction: Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial.
Saved in:
| Title: | Author Correction: Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial. |
|---|---|
| Authors: | Horwitz SM; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. horwitzs@mskcc.org.; New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY, USA. horwitzs@mskcc.org., Nirmal AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Rahman J; Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Xu R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Drill E; Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Galasso N; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ganesan N; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Davey T; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hancock H; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Perez L; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Maccaro C; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bahgat A; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Marzouk E; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Cathcart E; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Moskowitz A; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Noy A; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kumar A; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Jacobsen E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Fisher DC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Mehta-Shah N; Department of Medicine, Division of Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA., Kim YH; Division of Oncology, Stanford University, Stanford, CA, USA.; Department of Dermatology, Stanford University, Stanford, CA, USA., Khodadoust M; Division of Oncology, Stanford University, Stanford, CA, USA.; Department of Dermatology, Stanford University, Stanford, CA, USA., Kotlov N; BostonGene Corporation, Boston, MA, USA., Nikitina A; BostonGene Corporation, Boston, MA, USA., Kudryashova O; BostonGene Corporation, Boston, MA, USA., Zubareva V; BostonGene Corporation, Boston, MA, USA., Zornikova K; BostonGene Corporation, Boston, MA, USA., Shin N; BostonGene Corporation, Boston, MA, USA., Sorokina M; BostonGene Corporation, Boston, MA, USA., Degryse S; BostonGene Corporation, Boston, MA, USA., Postovalova E; BostonGene Corporation, Boston, MA, USA., Bagaev A; BostonGene Corporation, Boston, MA, USA., Hosszu K; Department of Pediatrics and Immune Discovery & Modeling Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., McAvoy D; Department of Pediatrics and Immune Discovery & Modeling Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Boelens JJ; Department of Pediatrics and Immune Discovery & Modeling Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Stem Cell Transplantation and Cellular Therapies, MSK Kids, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wu W; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center Collaborative Innovation Center for Cancer Medicine, Guangzhou, China., Ciantra Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Appelt JW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Trevisani C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Amaka S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Weinstock DM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Merck and Co., Rahway, NJ, USA., Vardhana SA; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. vardhans@mskcc.org.; New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY, USA. vardhans@mskcc.org.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. vardhans@mskcc.org. |
| Source: | Nature medicine [Nat Med] 2024 Dec; Vol. 30 (12), pp. 3778. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
